Loading…
Evolus, Inc. is projected to rise to $7.88 by 2027, a +28% move from its current price of $6.18. EOLS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.01 | $6.18 | $6.36 | +0.01% |
| May 30 | $5.93 | $6.18 | $6.44 | +0.03% |
| May 31 | $5.88 | $6.18 | $6.50 | +0.04% |
| Jun 1 | $5.84 | $6.18 | $6.55 | +0.06% |
| Jun 2 | $5.80 | $6.18 | $6.60 | +0.07% |
| Jun 3 | $5.76 | $6.19 | $6.64 | +0.09% |
| Jun 4 | $5.73 | $6.19 | $6.68 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.73 | $6.19 | $6.68 | +0.10% |
| Week 2 | $5.56 | $6.19 | $6.90 | +0.20% |
| Week 3 | $5.43 | $6.20 | $7.07 | +0.31% |
| Week 4 | $5.33 | $6.21 | $7.23 | +0.41% |
| Week 5 | $5.24 | $6.21 | $7.37 | +0.51% |
| Week 6 | $5.16 | $6.22 | $7.50 | +0.61% |
| Week 7 | $5.09 | $6.22 | $7.62 | +0.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evolus, Inc. is a performance beauty company that delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults, and Evolysse, a collection of injectable hyaluronic acid gels, which includes products for mid face, nasolabial folds, lips and eyes.
The company was incorporated in 2012 and is headquartered in Newport Beach, California. It is categorized in Healthcare.
Evolus, Inc. (EOLS) is currently trading at $6.09 per share. Its market capitalization is $401.06M, and it ranks 3226 by market cap.
Near-term price action is reflected by a 30-day range of $5.00 to $7.42, with a support level at $4.33 and a resistance at $6.72.
The forecast shows a long-run price path with a 2026 average of $6.09; from 2027 onward, the averages rise, culminating in a 2050 average of $32.55 and a 434.5 ROI.
Overall, the outlook points to a bullish multi-year trajectory, with progressively higher averages and strong ROI in later years.
A major floor 41.4% below — a decisive break under it would weaken the trend.
The nearest floor, 26.7% below — buyers have tended to step in here.
The nearest ceiling, 8.7% above — a clean break opens room to run.
A major ceiling 29.4% above — clearing it would confirm fresh momentum.
Key EOLS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EOLS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.31 | Sell | $6.28 | Sell |
| MA 10 | $6.44 | Sell | $6.30 | Sell |
| MA 20 | $6.20 | Sell | $6.11 | Buy |
| MA 50 | $5.22 | Buy | $5.60 | Buy |
| MA 100 | $5.08 | Buy | $5.57 | Buy |
| MA 200 | $5.95 | Buy | $6.36 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.83 | Neutral |
| Stoch RSI (14) | 5.61 | Buy |
| CCI (20) | -4.79 | Neutral |
| Williams %R (14) | -85.71 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -2.83 | Sell |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 14.29 | Buy |
| TRIX (15) | 1.12 | Buy |
| Awesome (5,34) | 0.68 | Buy |
| Ultimate (7,14,28) | 43.21 | Neutral |
| Momentum (10) | -0.32 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 6.14 | Buy |
| ADX (14) | 31.58 | Buy |
| ATR (14) | 0.15 | Info |
Sentiment in the near term is NEUTRAL. The RSI14 is 50, with a 50-day moving average of $5.18 and a 200-day moving average of $5.94.
In the next 30 days, the stock trades within a $5.00 to $7.42 range. Key support sits at $4.33 and resistance at $6.72, framing a balanced to cautious near-term outlook.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.94 | $6.18 | $8.19 | 0% | Neutral | |
| $6.22 | $7.88 | $10.61 | +28% | Bullish | |
| $7.39 | $9.64 | $13.47 | +56% | Bullish | |
| $7.24 | $9.68 | $13.92 | +57% | Bullish | |
| $7.97 | $10.88 | $16.05 | +76% | Bullish | |
| $8.09 | $11.26 | $16.98 | +82% | Bullish | |
| $7.47 | $10.60 | $16.29 | +71% | Bullish | |
| $8.88 | $12.82 | $20.06 | +107% | Bullish | |
| $10.45 | $15.34 | $24.40 | +148% | Bullish | |
| $11.07 | $16.51 | $26.67 | +167% | Bullish | |
| $13.76 | $22.05 | $37.95 | +257% | Bullish | |
| $21.45 | $38.93 | $73.53 | +530% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.94 | $6.18 | $7.25 | +0.00% |
| June 2026 | $5.32 | $6.25 | $7.53 | +1.19% |
| July 2026 | $5.28 | $6.26 | $7.65 | +0.14% |
| August 2026 | $5.04 | $6.02 | $7.44 | -3.86% |
| September 2026 | $5.02 | $6.03 | $7.52 | +0.18% |
| October 2026 | $5.25 | $6.34 | $7.96 | +5.10% |
| November 2026 | $5.30 | $6.43 | $8.14 | +1.49% |
| December 2026 | $5.28 | $6.43 | $8.19 | -0.04% |
Click any year to see its month-by-month EOLS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Evolus, Inc.'s 2026 outlook centres on $6.18, within a $3.94 to $8.19 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, EOLS could reach as high as $10.61, with a base case around $7.88 and support toward $6.22 — roughly +28% from $6.18. Buyers look set to stay in control over this stretch.
Expect EOLS to range from $7.39 to $13.47 through 2028. The $9.64 average target implies a +56% move from current prices. That is up +22% on the projected 2027 average. Momentum favours further upside here.
The EOLS price prediction for 2029 points to an average of $9.68 (low $7.24, high $13.92) — a potential gain of +57% on today's $6.18. Buyers look set to stay in control over this stretch.
In 2030, EOLS is projected to trade between $7.97 and $16.05, averaging $10.88 — a potential gain of +76% from today's $6.18. That is up +12% on the projected 2029 average. Momentum favours further upside here.
Evolus, Inc.'s 2031 outlook centres on $11.26, within a $8.09 to $16.98 range. That is up +3% on the projected 2030 average. That marks a +82% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, EOLS could reach as high as $16.29, with a base case around $10.60 and support toward $7.47 — roughly +71% from $6.18. Momentum favours further upside here.
Expect EOLS to range from $8.88 to $20.06 through 2033. The $12.82 average target implies a +107% move from current prices. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The EOLS price prediction for 2034 points to an average of $15.34 (low $10.45, high $24.40) — a potential gain of +148% on today's $6.18. Momentum favours further upside here.
In 2035, EOLS is projected to trade between $11.07 and $26.67, averaging $16.51 — a potential gain of +167% from today's $6.18. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Evolus, Inc.'s 2040 outlook centres on $22.05, within a $13.76 to $37.95 range. That is up +34% on the projected 2035 average. That marks a +257% change versus current levels. Momentum favours further upside here.
By 2050, EOLS could reach as high as $73.53, with a base case around $38.93 and support toward $21.45 — roughly +530% from $6.18. Buyers look set to stay in control over this stretch.
Investing $1,000 in EOLS today (≈ 161.812298 EOLS) could be worth
$6,298.96
+$5,298.96 (+530%) by 2050 · US Dollar
Based on the average projected EOLS price of $38.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EOLSwould be worth at today's price.
$1,000 invested in EOLS on May 27, 2025 (≈ 101.936795 EOLS) would be worth
$629.97
-$370.03 (-37.0%) today · 0.63× · US Dollar
Based on a EOLS entry price of $9.81 vs. today's $6.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.59 | $937.78 | -6.2% |
| 1 month ago | $5.22 | $1,183.91 | +18.4% |
| 3 months ago | $4.49 | $1,376.39 | +37.6% |
| 6 months ago | $7.16 | $863.13 | -13.7% |
| 1 year ago | $9.81 | $629.97 | -37.0% |
| All time (5.0y) ago | $11.29 | $547.39 | -45.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EOLS forecast.
Our base-case forecast reaches $12.00 around 2033.
Implied market cap at $12.00: $790.26M
The multi-year forecast portrays a bullish trajectory across the horizon years. In 2027, the average price is $7.48 with a bullish sentiment and a 22.8 ROI; in 2028, the average rises to $9.04 with a 48.4 ROI, and in 2029 the average is also $9.04 with a 48.5 ROI.
By 2030, the average is $10.10 and the ROI is 65.8, with sentiment BULLISH. The forecast continues to climb through 2031 ($10.21, 67.7), 2032 ($9.45, 55.1), and 2033 ($11.34, 86.2).
Further out, 2034 shows an average of $13.42 with a 120.3 ROI and 2035 an average of $14.48 with a 137.7 ROI. By 2040, the average is $18.41 with a 202.3 ROI, and by 2050 the average reaches $32.55 with a 434.5 ROI and a bullish sentiment. These figures illustrate a substantial long-run upside but are estimates, not guarantees, and depend on future market conditions.
Tap a question to reveal the answer.
The forecast for 2030 shows an average of $10.10 with a min of $7.33 and a max of $15.04; ROI is 65.8 and sentiment is BULLISH.
The forecast indicates a bullish trend starting from 2027 onward, with 2027 avg $7.48, 2028 $9.04, 2029 $9.04, 2030 $10.10 (ROI 65.8), 2040 $18.41 (ROI 202.3), and 2050 $32.55 (ROI 434.5), with sentiment consistently BULLISH in later years.
The 2050 forecast maximum is $62.50, while the 2050 average is $32.55, so a path to $50 is within the extreme forecast scenario but not guaranteed.
Current price is $6.09 and market cap is $401.06M.
The 30-day range is $5.00 to $7.42, RSI is 50, SMA50 is $5.18, SMA200 is $5.94, with support at $4.33 and resistance at $6.72. The sentiment is NEUTRAL.
Evolus, Inc. Community Discussion
0Share your Evolus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.